Table 2.

 Baseline demographic characteristics of trial participants

	Standard therapy (n = 173)		Povidone-iodine (n = 185)
	No	%	No	%
Age at presentation
<10	10	5.8	14	7.6
10–19	28	16.2	38	20.5
20–29	39	22.5	40	21.6
30–39	29	16.8	40	21.6
40–49	30	17.3	30	16.2
50+	37	21.4	23	12.4
Sex
Male	126	72.8	114	61.6
Female	47	27.2	71	38.4